Pharmaceutical Sterility Testing Market Size and Share Analysis Report by Type, Product Type, Test Type, Application, End User

Description

The pharmaceutical sterility testing market will reach USD 2,953.9 million by 2030, growing at a rate of 11.2% during 2023-2030. This is because of the development of biotech and pharma firms, an increase in their R&D activities, an increase in the incidence of diseases, and substantial government spending on the healthcare industry.

The increasing occurrence of diseases in the pest has brought about an increase in R&D activities for the manufacturing of effective and safe therapeutics. Regarding this, the continuing studies on the preventing severe viral infections, such as the novel coronavirus, and those centered on the expansion of effective and safe vaccines have a positive impact on the industry.

The occurrence of hematological malignancies is increasing. As per the Leukemia & Lymphoma Society, every 3 minutes, a person is identified with leukemia, myeloma, or lymphoma in the U.S. Biopharma, for example gene, and immune cell therapies are quickly being accepted as a substitute treatment for hematological cancers. This is due to the fact that such therapeutics have high effectiveness and efficacy against these kinds of diseases.

The outsourcing category led the industry, with a 60% share, in 2022. This is due to the fact that outsourcing is becoming popular among small and medium-sized pharma firms because of the advantages provided to them.

Furthermore, for pharma firms, outsourcing surges therapeutic expertise and working efficiency, makes on demand services accessible, and assists in the development of their geographical presence.

Moreover, many small and medium-sized companies do not have the satisfactory resources for fulfilling their requirements for quality sterility testing and, consequently, desire outsourcing to pass FDA rules.

North America pharmaceutical sterility testing market had a major share of 40%, in 2022. This is credited to the presence of leading pharma and biopharma players, increasing R&D activities in the biotech and pharma industry, increasing number of product introductions, high occurrence of chronic ailments, and supportive policies of the government for the setup of R&D facilities.

Furthermore, the existence of strong healthcare policies, strict drug approval needs, increasing public consciousness of drug safety, increasing acceptance of pioneering technologies, and the launch of gene and cell therapies for treating more than a few hematologic malignancies are resultant in the development of the regional industry.

Furthermore, Europe follows North America in terms of revenue share. This is attributable to the formation of universal public healthcare systems in numerous nations in the region, which has considerably increased the requirement for healthcare products. The employment of stringent regulatory policies with regards to the safety of drugs is another key factor contributing to the growth of the industry.

The increasing acceptance of digital platforms has a positive impact on the demand for pharmaceutical sterility testing, and this will be the trend in the years to come as well.

Product Code: 12675

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by product type
- 1.4.3. Market size breakdown, by test type
- 1.4.4. Market size breakdown, by application
- 1.4.5. Market size breakdown, by end user
- 1.4.6. Market size breakdown, by region
- 1.4.7. Market size breakdown, by country
1.5. Market Data Reporting Unit
- 1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics
- 6.1.1. Trends
- 6.1.2. Drivers
- 6.1.3. Restraints/challenges
- 6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter's Five Forces Analysis
- 6.3.1. Bargaining power of buyers
- 6.3.2. Bargaining power of suppliers
- 6.3.3. Threat of new entrants
- 6.3.4. Intensity of rivalry
- 6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview
7.2. Market Revenue, by Type (2017-2030)
7.3. Market Revenue, by Product type (2017-2030)
7.4. Market Revenue, by Test type (2017-2030)
7.5. Market Revenue, by Application (2017-2030)
7.6. Market Revenue, by End user (2017-2030)
7.7. Market Revenue, by Region (2017-2030)

Chapter 8. North America Market

8.1. Overview
8.2. Market Revenue, by Type (2017-2030)
8.3. Market Revenue, by Product type (2017-2030)
8.4. Market Revenue, by Test type (2017-2030)
8.5. Market Revenue, by Application (2017-2030)
8.6. Market Revenue, by End user (2017-2030)
8.7. Market Revenue, by Country (2017-2030)

Chapter 9. Europe Market

9.1. Overview
9.2. Market Revenue, by Type (2017-2030)
9.3. Market Revenue, by Product type (2017-2030)
9.4. Market Revenue, by Test type (2017-2030)
9.5. Market Revenue, by Application (2017-2030)
9.6. Market Revenue, by End user (2017-2030)
9.7. Market Revenue, by Country (2017-2030)

Chapter 10. APAC Market

10.1. Overview
10.2. Market Revenue, by Type (2017-2030)
10.3. Market Revenue, by Product type (2017-2030)
10.4. Market Revenue, by Test type (2017-2030)
10.5. Market Revenue, by Application (2017-2030)
10.6. Market Revenue, by End user (2017-2030)
10.7. Market Revenue, by Country (2017-2030)

Chapter 11. LATAM Market

11.1. Overview
11.2. Market Revenue, by Type (2017-2030)
11.3. Market Revenue, by Product type (2017-2030)
11.4. Market Revenue, by Test type (2017-2030)
11.5. Market Revenue, by Application (2017-2030)
11.6. Market Revenue, by End user (2017-2030)
11.7. Market Revenue, by Country (2017-2030)

Chapter 12. MEA Market

12.1. Overview
12.2. Market Revenue, by Type (2017-2030)
12.3. Market Revenue, by Product type (2017-2030)
12.4. Market Revenue, by Test type (2017-2030)
12.5. Market Revenue, by Application (2017-2030)
12.6. Market Revenue, by End user (2017-2030)
12.7. Market Revenue, by Country (2017-2030)

Chapter 13. U.S. Market

13.1. Overview
13.2. Market Revenue, by Type (2017-2030)
13.3. Market Revenue, by Product type (2017-2030)
13.4. Market Revenue, by Test type (2017-2030)
13.5. Market Revenue, by Application (2017-2030)
13.6. Market Revenue, by End user (2017-2030)

Chapter 14. Canada Market

14.1. Overview
14.2. Market Revenue, by Type (2017-2030)
14.3. Market Revenue, by Product type (2017-2030)
14.4. Market Revenue, by Test type (2017-2030)
14.5. Market Revenue, by Application (2017-2030)
14.6. Market Revenue, by End user (2017-2030)

Chapter 15. Germany Market

15.1. Overview
15.2. Market Revenue, by Type (2017-2030)
15.3. Market Revenue, by Product type (2017-2030)
15.4. Market Revenue, by Test type (2017-2030)
15.5. Market Revenue, by Application (2017-2030)
15.6. Market Revenue, by End user (2017-2030)

Chapter 16. France Market

16.1. Overview
16.2. Market Revenue, by Type (2017-2030)
16.3. Market Revenue, by Product type (2017-2030)
16.4. Market Revenue, by Test type (2017-2030)
16.5. Market Revenue, by Application (2017-2030)
16.6. Market Revenue, by End user (2017-2030)

Chapter 17. U.K. Market

17.1. Overview
17.2. Market Revenue, by Type (2017-2030)
17.3. Market Revenue, by Product type (2017-2030)
17.4. Market Revenue, by Test type (2017-2030)
17.5. Market Revenue, by Application (2017-2030)
17.6. Market Revenue, by End user (2017-2030)

Chapter 18. Italy Market

18.1. Overview
18.2. Market Revenue, by Type (2017-2030)
18.3. Market Revenue, by Product type (2017-2030)
18.4. Market Revenue, by Test type (2017-2030)
18.5. Market Revenue, by Application (2017-2030)
18.6. Market Revenue, by End user (2017-2030)

Chapter 19. Spain Market

19.1. Overview
19.2. Market Revenue, by Type (2017-2030)
19.3. Market Revenue, by Product type (2017-2030)
19.4. Market Revenue, by Test type (2017-2030)
19.5. Market Revenue, by Application (2017-2030)
19.6. Market Revenue, by End user (2017-2030)

Chapter 20. Japan Market

20.1. Overview
20.2. Market Revenue, by Type (2017-2030)
20.3. Market Revenue, by Product type (2017-2030)
20.4. Market Revenue, by Test type (2017-2030)
20.5. Market Revenue, by Application (2017-2030)
20.6. Market Revenue, by End user (2017-2030)

Chapter 21. China Market

21.1. Overview
21.2. Market Revenue, by Type (2017-2030)
21.3. Market Revenue, by Product type (2017-2030)
21.4. Market Revenue, by Test type (2017-2030)
21.5. Market Revenue, by Application (2017-2030)
21.6. Market Revenue, by End user (2017-2030)

Chapter 22. India Market

22.1. Overview
22.2. Market Revenue, by Type (2017-2030)
22.3. Market Revenue, by Product type (2017-2030)
22.4. Market Revenue, by Test type (2017-2030)
22.5. Market Revenue, by Application (2017-2030)
22.6. Market Revenue, by End user (2017-2030)

Chapter 23. Australia Market

23.1. Overview
23.2. Market Revenue, by Type (2017-2030)
23.3. Market Revenue, by Product type (2017-2030)
23.4. Market Revenue, by Test type (2017-2030)
23.5. Market Revenue, by Application (2017-2030)
23.6. Market Revenue, by End user (2017-2030)

Chapter 24. South Korea Market

24.1. Overview
24.2. Market Revenue, by Type (2017-2030)
24.3. Market Revenue, by Product type (2017-2030)
24.4. Market Revenue, by Test type (2017-2030)
24.5. Market Revenue, by Application (2017-2030)
24.6. Market Revenue, by End user (2017-2030)

Chapter 25. Brazil Market

25.1. Overview
25.2. Market Revenue, by Type (2017-2030)
25.3. Market Revenue, by Product type (2017-2030)
25.4. Market Revenue, by Test type (2017-2030)
25.5. Market Revenue, by Application (2017-2030)
25.6. Market Revenue, by End user (2017-2030)

Chapter 26. Mexico Market

26.1. Overview
26.2. Market Revenue, by Type (2017-2030)
26.3. Market Revenue, by Product type (2017-2030)
26.4. Market Revenue, by Test type (2017-2030)
26.5. Market Revenue, by Application (2017-2030)
26.6. Market Revenue, by End user (2017-2030)

Chapter 27. Saudi Arabia Market

27.1. Overview
27.2. Market Revenue, by Type (2017-2030)
27.3. Market Revenue, by Product type (2017-2030)
27.4. Market Revenue, by Test type (2017-2030)
27.5. Market Revenue, by Application (2017-2030)
27.6. Market Revenue, by End user (2017-2030)

Chapter 28. South Africa Market

28.1. Overview
28.2. Market Revenue, by Type (2017-2030)
28.3. Market Revenue, by Product type (2017-2030)
28.4. Market Revenue, by Test type (2017-2030)
28.5. Market Revenue, by Application (2017-2030)
28.6. Market Revenue, by End user (2017-2030)

Chapter 29. U.A.E. Market

29.1. Overview
29.2. Market Revenue, by Type (2017-2030)
29.3. Market Revenue, by Product type (2017-2030)
29.4. Market Revenue, by Test type (2017-2030)
29.5. Market Revenue, by Application (2017-2030)
29.6. Market Revenue, by End user (2017-2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. Steris plc
- 31.1.1. Business overview
- 31.1.2. Product and service offerings
- 31.1.3. Key financial summary
31.2. Boston Analytical
- 31.2.1. Business overview
- 31.2.2. Product and service offerings
31.3. Sartorius AG
- 31.3.1. Business overview
- 31.3.2. Product and service offerings
31.4. Arbro Pharmaceuticals Private Limited & Auriga Research Private Limited
- 31.4.1. Business overview
- 31.4.2. Product and service offerings
31.5. Lucideon Limited
- 31.5.1. Business overview
- 31.5.2. Product and service offerings
31.6. Pace Analytical Life Sciences, LLC
- 31.6.1. Business overview
- 31.6.2. Product and service offerings
31.7. SGS SA
- 31.7.1. Business overview
- 31.7.2. Product and service offerings
- 31.7.3. Key financial summary
31.8. Sotera Health Company
- 31.8.1. Business overview
- 31.8.2. Product and service offerings
- 31.8.3. Key financial summary
31.9. Merck KGaA
- 31.9.1. Business overview
- 31.9.2. Product and service offerings
- 31.9.3. Key financial summary
31.10. Pall Corporation
- 31.10.1. Business overview
- 31.10.2. Product and service offerings
31.11. Charles River Laboratories International, Inc
- 31.11.1. Business overview
- 31.11.2. Product and service offerings
- 31.11.3. Key financial summary
31.12. Thermo Fisher Scientific Inc
- 31.12.1. Business overview
- 31.12.2. Product and service offerings
- 31.12.3. Key financial summary
31.13. Almac Group Limited
- 31.13.1. Business overview
- 31.13.2. Product and service offerings
31.14. Pacific BioLabs
- 31.14.1. Business overview
- 31.14.2. Product and service offerings
31.15. BIOMERIEUX S.A.
- 31.15.1. Business overview
- 31.15.2. Product and service offerings
- 31.15.3. Key financial summary

Chapter 32. Appendix

32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports

Pharmaceutical Sterility Testing Market Size and Share Analysis Report by Type, Product Type, Test Type, Application, End User - Global Industry Demand Forecast to 2030